Day: February 28, 2022

HOLLYWOOD, Fla., Feb. 28, 2022 (GLOBE NEWSWIRE) — NV5 Global, Inc. (Nasdaq: NVEE) (“NV5” or the “Company”), a provider of compliance, technology, and engineering consulting solutions, today reported financial results for the fourth quarter and full year ended January 1, 2022. “NV5 delivered another record year for revenues and profitability in 2021, including significant growth in net income, Adjusted EBITDA, Adjusted EBITDA margins, and earnings per share. Increased profitability was driven by the growing scale of our operations as well as our mix of high-margin offerings including utility services, environmental solutions, and energy efficiency. We completed eight strategic acquisitions in 2021 to expand our marine geospatial offering, strengthen our growing energy efficiency and clean energy business,...

CAMBRIDGE, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, announced today the U.S. Patent and Trademark Office (USPTO) issued another favorable decision to the Broad Institute, Inc. (Broad) involving specific patents for CRISPR/Cas9 editing in human cells. Pending an appeal to the Federal Circuit, this decision ends the U.S. patent interference between the University of California, the University of Vienna, and Emmanuelle Charpentier (collectively, CVC) and Broad. This action by the USPTO is the second favorable decision determining Broad as the first group to invent the use of CRISPR/Cas9 for editing DNA in those cells necessary for making gene editing medicines for people. With this decision, the USPTO has clearly determined that CVC was not the first to invent...

CSU Phase 1b multi-dose data expected in July CDX-0159 subcutaneous formulation study results fully support transition to SubQ dosing; Phase 2 studies in CSU and CIndU to initiate Q2 2022 Expanded development of CDX-0159 into Eosinophilic Esophagitis (EoE) Well capitalized with $408.3 million in cash, cash equivalents, and marketable securities expected to fund activities through 2025 Conference call today Monday February 28th, 4:30pm ETHAMPTON, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported financial results for the fourth quarter and year ended December 31, 2021 and provided a corporate update. “Celldex made significant progress over the past year in advancing our pipeline, as marked by successful clinical results from our Phase 1b study with CDX-0159 demonstrating a 95% complete...

NEW YORK, Feb. 28, 2022 (GLOBE NEWSWIRE) — Apollo Investment Corporation (NASDAQ: AINV) or the “Company,” announced today that Tanner Powell, the President of the Company and the Chief Investment Officer for the Company’s Investment Adviser, is scheduled to participate virtually on a BDC panel at the 2022 RBC Capital Markets Financial Institutions Conference on Tuesday, March 8, 2022 at 2:00 PM Eastern Time. A live webcast of the panel discussion will be available on the Investor Relations section of Apollo Investment Corporation’s website at www.apolloic.com. For those unable to listen to the live webcast, a replay will be available on the Company’s website shortly after the event. About Apollo Investment Corporation Apollo Investment Corporation (NASDAQ: AINV) is a closed-end investment company that has elected to be treated...

BOISE, Idaho, Feb. 28, 2022 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU), announced today that it will hold its fiscal second quarter earnings conference call on Tuesday, March 29, 2022, at 2:30 p.m. Mountain time. The call will be webcast live at http://investors.micron.com/. Webcast replays of presentations can be accessed from Micron’s Investor Relations website and will be available for approximately one year after the call. About Micron Technology, Inc.  We are an industry leader in innovative memory and storage solutions transforming how the world uses information to enrich life for all. With a relentless focus on our customers, technology leadership, and manufacturing and operational excellence, Micron delivers a rich portfolio of high-performance DRAM, NAND and NOR memory and storage products through our Micron®...

Awilco Drilling PLC reports contract revenue of USD 1.0 million (USD 7.4 million Q3), EBITDA loss of USD 7.8 million (USD 3.1 million loss in Q3) and a net loss of USD 50.7 million, (USD 4.6 million loss in Q3). Net loss includes impairment of USD 31.0 million. Revenue efficiency was 90.1% during the quarter (97.4% in Q3). Operational uptime was 100% during the quarter (99.9% in Q3). Please see attached for the Q4 2021 report. A digital presentation will be held on 1 March 2022 at 11:00 UK time (12:00pm CET / 06:00 EST). The presentation will be available for download on the Investor Relations section (go to “Press Releases”) at www.awilcodrilling.com prior to the meeting. There will be a Q&A session after the presentation. To join the digital meeting, please click this link or copy and paste the following address into...

Daix (France), Long Island City (New York, United States), February 28, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases with significant unmet medical needs, today announced that its management team will host a webcast to present the Company’s full-year financial results for 2021 on Tuesday, March 8, 2022. Inventiva’s 2021 full-year financial results will be released on Monday, March 7, 2022 at 4:00 pm (New York), 10:00 pm (Paris). Frédéric Cren, Chairman, CEO and cofounder of Inventiva, Pierre Broqua, Chief Scientific Officer and cofounder of Inventiva, Jean Volatier, Chief Financial Officer of Inventiva, and Michael Cooreman, Chief Medical Officer of Inventiva,...

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Feb. 28, 2022 (GLOBE NEWSWIRE) — Zacatecas Silver Corp. (“Zacatecas Silver” or the “Company”) (TSXV: ZAC; OTC: ZCTSF) is pleased to announce that it has entered into an agreement with Clarus Securities Inc. as lead agent and sole bookrunner on behalf of a syndicate of agents (collectively, the “Agents”), whereby the Agents will raise up to $15,000,700 (the “Offering”) through an Offering of up to 13,637,000 subscription receipts of the Company (the “Subscription Receipts”) to be priced at $1.10 per Subscription Receipt. Each Subscription Receipt is convertible into one Unit of the Company (each, a “Unit”) upon the completion of certain Escrow...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES VANCOUVER, British Columbia, Feb. 28, 2022 (GLOBE NEWSWIRE) — Further to its news release dated February 23, 2022, Abacus Mining & Exploration Corporation (“Abacus” or the “Company”) (TSXV: AME) is pleased to announce an increase to the non-brokered private placement (“Offering”), now for proceeds of up to $700,000 through the issuance of up to 11,666,666 units (“Units”) at a price of $0.06 per Unit. Each Unit will consist of one common share of the Company and one half of one non-transferable common share purchase warrant, with each warrant exercisable to purchase one common share of the Company at a price of $0.10 per common share for a period of 2 years from the date of closing of the Offering. Proceeds from the Offering will be applied...